A wide variety of cells usefully but sometimes destructively produce nitric oxide via inducible nitric oxide synthase (iNOS). Data obtained by gel shift analysis and reporter assays have linked murine iNOS gene induction by cytokines and bacterial products with the binding of a number of proteins to a proximal promoter, as well as to a distal enhancer of the iNOS gene. Nevertheless, these techniques do not necessarily reflect protein occupation of sites in vivo. To address this, we have used dimethyl sulphate in vivo footprinting to determine binding events in the two murine iNOS transcription control regions, using a classical lipopolysaccharide induction of RAW 264.7 macrophages. Protein-DNA interactions are absent before activation. Exposure to lipopolysaccharide induces protection at a NF-κB site and hypersensitivity at a shared gammaactivated site/interferon-stimulated response element within the enhancer. Protections are seen at a NF-IL6, and an Oct site within the promoter. We also observe modulations in guanine methylation at two regions which do not correspond to any known putative binding elements. Furthermore, we confirm the probable involvement of interferon regulatory factor-1 (binding to its -901 to -913 site) and the binding of NF-κB to its proximal site. Our data demonstrate an abundance of hitherto-unrecognised protein-DNA binding events upon simple lipopolysaccharide activation of the iNOS gene and suggests a role for protein-protein interactions in its transcriptional induction.
INTRODUCTION
Nitric oxide (NO) is a well-characterised cytotoxic molecule, with a dual potential for either beneficial effects, e.g. micro-organism (1-3) and tumour cell killing (4, 5) , or detrimental effects on the host organism, e.g. inflammation (6) , genotoxicity (7) or immunosuppression (8) . In many cell types, the crucial checkpoint for production of NO is at the level of transcription of the inducible nitric oxide synthase (iNOS) gene. Transcriptional control of iNOS has been widely studied in murine macrophages (9, 10) although less is known about human iNOS. Some notable similarities exist in the 5′-untranslated regions (5′-UTR) of the human (11) and the mouse genes. Although there is recent evidence for TATA-independent mRNA transcription of the murine and human genes (12) , a clear majority of transcripts begin just downstream of a TATA box. A 400 base pair (bp) region immediately upstream of the main transcription start site for the human (11) and murine (9, 10) iNOS genes contains a number of consensus sequences for transcription factors believed to be important in cytokine-or lipopolysaccharide-(LPS) induced gene expression. These include three nuclear factor interleukin 6 (NF-IL6) binding sites, one tumour necrosis factor response element (TNF-RE), one NF-κB binding site and one Oct site. A number of groups have demonstrated the importance of this proximal promoter region for LPS-stimulated murine iNOS transcription, and also defined a region further upstream which is necessary for both a full LPS activation and the synergistic effect of LPS and γ-interferon (9, 10) . This distal enhancer region also contains numerous elements with the potential for binding trans-acting factors. Amongst these is another NF-κB site and several interferon regulatory factor binding elements (IRF-E). The importance of at least one of these IRF-Es has been shown in reporter assays using deletion constructs (13) and in mice which have a targeted disruption of the IRF-1 gene (14) .
Nevertheless, despite the wealth of information available on the subject of murine iNOS transcription, all these studies, with the exception of the IRF-1 -/-mice, have been carried out in vitro using gel shift or reporter assays. Despite the usefulness of the latter, it is a technique that does not take into account the effects of DNA topology or chromosomal architecture. With respect to iNOS gene analysis, difficulties in eliminating a possible refractory effect on iNOS gene activation by trace contamination with LPS of the plasmid DNA used for transfection have been described (13, 15) . Furthermore, when one considers the large number of potential binding sites for transcription factors within the 5′-UTR of the iNOS gene, there are still gaps in our knowledge as to the protein-DNA binding events which must occur for a stable RNA polymerase II-transcription complex to be formed at the start site of iNOS mRNA synthesis. For these reasons we decided to investigate transcription of the iNOS gene using the technique of in vivo footprinting with ligation-mediated PCR. For its relevance to DNA-protein interactions in vivo, this method can be considered a benchmark against which other transcriptional assays should be judged (16) (17) (18) (19) . Our footprinting data of the promoter and the enhancer in mouse macrophages revealed a number of previously unidentified LPS-inducible interactions with the iNOS gene control regions. These include binding to the upstream of the two NF-κB sites and to a shared gamma-activated site/interferon-stimulated response element (GAS/ISRE). Very strong methylation protections of guanines within a NF-IL6 and an Oct site in the enhancer were observed. Methylation protections were also observed at two sites which correspond to no known consensus binding elements. Other data also confirmed the importance of one of the IRF-Es and the NF-κB site in the promoter.
MATERIALS AND METHODS
In vivo genomic DNA methylation RAW 264.7 cells (an established mouse macrophage cell line) were cultured to near-confluency in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% endotoxin-free fetal bovine serum (Hyclone) and gentamycin (40 µg/ml). They were then washed and treated with LPS (from E.coli serotype 0128:B12; Sigma) at 10 ng/ml in the growth medium, or with growth medium alone. After a 15 min or 3 h incubation, cells were washed twice with DMEM, removed from their culture flasks using a rubber policeman and resuspended in 1 ml culture medium buffered with 20 mM HEPES, pH 7.3, at 37_C, at a density of 20-30 × 10 6 cells/ml. Methylation was carried out at 20_C for 1 min by adding 0.1% or 0.5% dimethyl sulphate (DMS; Aldrich) to the cells (the quantity of DMS necessary was determined previously). The reaction was quenched by the addition of ice-cold phosphate-buffered saline (PBS) containing 2% β-mercaptoethanol, and the cells were then washed twice with the same solution. Cells remain viable after this treatment as assessed by trypan blue exclusion.
Genomic DNA extraction
Cells methylated in vivo, plus unmethylated cells for naked DNA controls (20-30 × 10 6 cells), were then lysed and digested in 3.3 ml 9 mM Tris-HCl (pH 8), 268 mM LiCl, 0.9 mM EDTA, 1.8% β-mercaptoethanol, 1.8% SDS and 600 µg/ml proteinase K, at 55_C for 3 h. The aqueous mixtures were then extracted sequentially with phenol, phenol/dichloromethane (1:1) and dichloromethane, followed by precipitation of the DNA twice and finally a 70% ethanol wash.
In vitro DNA genomic methylation
Unmethylated genomic DNA was resuspended in 200 µl TE buffer, and methylation was carried out at 20_C with 0.5% DMS for 30 s. The reaction was stopped by the addition of 50 µl 1.5 M NaCl, 3.4% β-mercaptoethanol, and the DNA was ethanol precipitated and then washed with 70% ethanol.
Piperidine cleavage of DNA methylated in vivo and in vitro DNA pellets were resuspended in 200 µl TE buffer and the cleavage reaction was carried out by adding 10% piperidine and heating at 90_C for 30 min. The DNA in each sample was then precipitated twice using ethanol and sodium acetate, washed with 70% ethanol, and resuspended in TE buffer. DNA concentrations were determined at 260 nm, and the samples were stored at -20_C.
Ligation-mediated PCR
To visualize the fragments in 1-2 µg genomic DNA, the ligation-mediated PCR method of Garrity and Wold (20) was used essentially as described, with the following modifications. For the first chain extension and radioactive extension steps, 0.25 and 0.5 U Vent polymerase, respectively, were used per sample. We found less smearing in the footprint analyses with this reduced amount of polymerase. The T4 DNA ligase was used at 1.5 U per sample. Sequencing gels were prepared using either 5% Long Ranger (Bioprobe Systems), or 6.5% acrylamide (BioRad) .
The primers used to analyze both strands of the promoter and enhancer regions (and the hybridization temperatures and positions relative to the transcriptional start site at +1) are as follows: Enhancer coding strand:
-830 to -800. P3. 5′-GCCAGGATCACACAGAAAAACCCTGTTCTGAGAAAC-3′ (69_C): -796 to -834.
Enhancer non-coding strand: P 1. 5′-GTCTGTGTACCTCAGACAA-3′ (55_C): -1062 to -1044. P 2. 5′-TGAGCTGACTTTGGGGACCATGCGA-3′ (63_C): -1027 to -1003. P 3. 5′-TTGGGGACCATGCGAAGATGAGTGGACCC-3′ (68_C):
-1017 to -989.
Promoter coding strand:
P1. 5′-CAGAGTCTCAGTCTTCAA-3′ (51_C): +34 to +17. P2. 5′-CTGTAAAGTTGTGACCCTGG-3′ (63_C): -8 to +12. P3. 5′-CTGTAAAGTTGTGACCCTGGCAGCA-3′ (69_C): -13 to +12.
Promoter non-coding strand:
P1. 5′-TTTTGAAGTGACTACGTGCT-3′ (54_C): -238 to -219. P2. 5′-AGGAAGAGATGGCCTTGCAT-3′ (65_C): -187 to -168. P3. 5′-AGGAAGAGATGGCCTTGCATGAGGATA-3′ (71_C): -187 to -161.
Gel shift assay
Nuclear protein extractions and gel shift analyses were carried out as previously described (21, 22) using an Oct consensus oligonucleotide (Promega) as probe.
RESULTS

Experimental strategy
In order to define protein-DNA binding events in the 5′-UTR of the murine iNOS gene, we used the method of in vivo footprinting with ligation-mediated PCR. In this technique, DMS diffuses rapidly into the nuclei of living cells and methylates guanine residues in the major groove of the DNA (16, 23) . Trans-acting factors interacting with the DNA inhibit, or quite commonly stimulate, guanine methylation within or adjacent to cis-acting elements, and using ligation-mediated PCR enables single copy gene control regions to be assayed from within an entire mammalian genome. We used the established murine macrophage cell line employed in most iNOS gene transcription studies, RAW 264.7, and a classic inducer of iNOS transcription, LPS, in order to visualize promoter/enhancer binding of transcription factors. Since iNOS is now known to be widely distributed in different cell types (3) and to be induced by a variety of stimuli, we considered it necessary to study the fundamental basis for iNOS transcription using the simplest model available. Moreover, in vivo footprinting demands uniform transcription of the gene under study within a homogeneous cell population (16) . The discussion of the results is limited to only those guanine residues that were consistently protected or hypermethylated in separate samples and in independent experiments.
Analysis of sites in uninduced cells
It is well established that iNOS messenger RNA is not readily detectable in unstimulated mouse macrophages (24) . Prior to induction with LPS, we found no clear evidence of stable protein occupation of either the enhancer or the promoter (Fig. 1A and B, Fig. 2A , B and C, lanes 1 and 2). Therefore, our data diminish the likelihood that within these two regions there exist constitutivelybound inhibitory factors such as IRF-2, a protein of the same family as IRF-1, with a similar DNA binding specificity, but transcriptionally repressive (25) .
LPS-induced binding to the enhancer element
Ligation-mediated PCR detected several changes in methylation sensitivity in the coding strand of the distal enhancer after LPS stimulation (Fig. 1A) . A protection was seen at one or both of the guanines (-906 and -907) at the centre of one of the IRF-Es (-901 to -913) after 3 h of LPS stimulation (Fig. 1A , compare lane 3 with lanes 1 and 2). This was not seen after 15 min of LPS stimulation (Fig. 1A, lane 4) . Protection at this site is indicative of the likely interaction of IRF-1 with this DNA target sequence; IRF-1 has been previously shown to be synthesized in murine macrophages in response to LPS (26) . Hypersensitivity was seen at one or more of the five adjacent guanines from -969 to -973 (Fig. 1A, lane 3) , but due to consistent compression in this region, we were unable to identify the exact modified residue(s). This hypersensitivity is representative of NF-κB activation and binding to its enhancer site. This was also observed after just 15 min of LPS stimulation (Fig. 1A, lane 4) , thus clearly demonstrating the speed of LPS-signal transduction through this pathway. After 15 min and 3 h of LPS induction, a further hypersensitivity was apparent at guanine -949 (Fig. 1A, lanes 4 and 3,  respectively) , which is adjacent to a GAS and within an ISRE. We used the other enhancer primer set to footprint the non-coding strand. The total amounts of fragments in each sample were slightly different (Fig. 1B) . Therefore, we assessed methylation changes using data from scans of the -LPS and +LPS samples as well as by comparing the relative importance of different fragments within individual samples. After 15 min and 3 h of LPS induction we found a hypomethylation in one or more of the guanines at -961 to -963 (Fig. 1B , compare the intensity of the compressed bands at -961 to -963 to bands at -955 or -945/-946 in lanes 4 and 3, in relation to the same comparisons for the in vitro and the -LPS samples in lanes 1 and 2, respectively). This data further confirms protein binding to the NF-κB site. The only other reproducible feature observed on the non-coding strand was a hypomethylation at -898/-899, detected after 3 h of LPS induction. The apparent protection of the guanine at -917 in the -LPS samples was not seen in several other experiments and therefore is not discussed further. No known factors bind at or adjacent to the region encompassing the guanine at -898/-899, apart from the probable binding of IRF-1 to its -901 to -913 site. The possibility of other unknown factor(s) binding to the local sequence around -898/-899 is currently being explored. Interestingly, the lack of reproducible changes at guanines -913 and -917, indicates a probable lack of factor binding at the -913 to -923 IRF-E under our experimental conditions.
LPS-induced binding to the promoter
Coding strand footprinting revealed a very strong hypersensitive site amongst the guanines at -83 to -86 of the proximal NF-κB site ( Fig. 2A, compare lane 3 with lanes 1 and 2) . Separation of the larger fragments also revealed protection of the -146 guanine within a NF-IL6 site (Fig. 2B, compare lane 3 with lanes 1 and 2) . Otherwise only small non-reproducible differences were seen.
Footprinting of the non-coding strand (Fig. 2C ) revealed an inducible occupation of guanines in the region of the transcriptional start site (i.e. at -8/-7 to +5, Fig. 2C, compare lanes 2  and 3) . Further evidence for the NF-κB site occupation was also obtained, since strong protections were seen at guanines -75, -76, -77 and -81 (Fig. 2C, compare lanes 2 and 3) . The protection of the guanine at -79 was relatively weaker. These data reinforce the importance of the proximal NF-κB site as previously described (9, 10) . Interestingly, a very strong protection was seen at guanine -58, which is within an Oct site (Fig. 2C, compare lanes 2 and 3) , indicating occupancy of this site in response to LPS stimulation. Consistent with this finding, we observed by gel shift analysis of nuclear extracts from RAW 264.7 cells, LPS-inducible protein binding to a consensus Oct site (Fig. 3) ; furthermore, LPS has been shown to increase the activity of Oct-2 in B cells (27) . Gel shift analysis of Oct binding proteins. RAW 264.7 macrophages were treated with 100 ng/ml LPS or without, for 3 h, prior to extraction of nuclear proteins and gel shift analysis using a labelled oligonucleotide containing a consensus Oct binding site. Specificity of binding was confirmed using a 25-fold excess of unlabelled Oct oligonucleotide or an unlabelled oligonucleotide containing the -971 to -962 κB site from the murine iNOS enhancer element.
It should be noted that very little difference in sensitivity to methylation was seen at guanine -59 within the Oct site using the coding strand primer set ( Fig. 2A) . Similarly, we were unable to gain further evidence of the binding of NF-IL6 to its -142 to -150 site using the non-coding primer set, due to the proximity of the site to the 3′-end of the radiolabelled primer (at -161). Nevertheless, it is not obligatory for a transcription factor to influence methylation at all available residues on both strands within its DNA binding site. In effect, the footprinting data provides the first in vivo evidence for the involvement of NF-IL6 and Oct-binding protein(s) in iNOS transcriptional activation.
LPS-inducible protection of a guanine at -45 was also observed (Fig. 2C, compare lanes 2 and 3) . This residue does not lie within or adjacent to a known site. It is possible that an as yet unrecognised factor binds at this region. However, structural alterations of the DNA due to widespread transcription factor binding at other sites may decrease the availability of this residue for methylation giving rise to the observed effect.
DISCUSSION
In this study, we provide evidence for the involvement of numerous LPS-inducible factors binding to sites within the murine iNOS gene control regions (Fig. 4) . Previous studies have implicated NF-κB (9, 10, 22, 28, 29) and IRF-1 (13, 14) in the transcriptional response of the iNOS gene to LPS and IFN-γ. Our data further suggest a role for NF-κB in the induced transcription of the murine iNOS gene after LPS stimulation. Significantly, we see binding to both putative sites. Although the importance of the NF-κB site in the iNOS promoter is well-recognised, this is the strongest evidence yet of a role for the NF-κB site within the enhancer. Likewise, our data implicate IRF-1 in LPS-induced iNOS gene expression. Hypomethylation was seen within the -901 to -913 IRF-E (Fig. 1A) and not in the -913 to -923 IRF-E (Fig. 1B) . Other studies using gel shift and reporter assays have indicated the necessity of only the -913 to -923 site in RAW 264.7 cells activated with IFN-γ (13) and that in an IRF-1-transfected cell line the two motifs mediate a synergistic induction (14) . In vivo, it may be that within the intact enhancer in RAW 264.7 cells, only one site is fully available to IRF-1. Alternatively, activation of macrophages by IFN-γ may cause factor binding and structural alteration of the 5′-UTR, in a manner different from that induced by LPS, thus exposing the -913 to -923 site. Further footprinting analyses using IFN-γ should resolve this point.
Previous studies have shown that macrophages from IRF-1 -/-mice produce very low levels of NO after LPS stimulation (14) . This has been postulated (13) to be due to the role of IRF-1 in the synthesis of the unidentified 115 kDa protein which participates in the assembly of the LPS-activated transcription factor complex on the proximal NF-κB site. However, our results indicate that LPS activation of the iNOS gene may require the IRF-1 pathway in a more direct sense, in that LPS can also stimulate direct protein occupation of the -901 to -913 IRF site.
As well as providing further data suggestive of the involvement of NF-κB and IRF-1 in iNOS gene induction, we demonstrate the possible role of other factors. We observe protection within the Oct site of the iNOS promoter and our gel shift analysis shows nuclear activation of a number of proteins binding to an oligonucleotide containing a consensus Oct sequence. A recent in vitro study also suggested the involvement of the Oct site in iNOS transcription (30) . Furthermore, we detected protection within a NF-IL6 site. To date, there has been no in vitro evidence linking NF-IL6 with iNOS gene induction, although it is known that NF-IL6 can be induced by LPS (31) . Recent work has demonstrated a normal production of NO, stimulated by LPS and IFN-γ, in macrophages from NF-IL6 -/-mice (32). Nevertheless, this does not automatically negate the potential importance of NF-IL6 in iNOS transcription, since as these authors suggest, other members of the C/EBP transcription factor family, such as NF-IL6β, could substitute for the deleted NF-IL6.
Interestingly, after just 15 min of LPS exposure a hypersensitivity was seen at an ISRE/GAS within the enhancer; no protection was seen at the -901 to -913 IRF-E at this time (Fig. 1A, lanes  1, 2 and 4) . The hypersensitivity was likely due to the binding of either interferon-stimulated gene factor 3 (ISGF3), or gammaactivated factor (GAF), to the ISRE or the GAS, respectively. Activation and nuclear translocation of ISGF3 and GAF is rapid and unlike IRF-1 does not require protein synthesis (33) . One of the constituent members of the ISGF3 protein complex, p48, is structurally-related to the IRF family (33) and a relationship between ISGF3 and IRF-1, in that the former initially activates and the latter maintains expression of some genes containing ISRE promoters has been suggested (34, 35) . Our data may be consistent with this possibility, although the role of GAF cannot be excluded.
Protected guanines at -898/-899 and -45 were consistently observed upon LPS stimulation. At present, the significance, if any, of these changes with respect to iNOS gene induction is unclear. Furthermore, an occupation of guanines in the region of the transcriptional start site was also detected. These protected residues indicate that upon LPS stimulation, at least one nuclear factor probably interacts with residues in the major groove of the iNOS gene transcription start site in vivo.
Importantly, it should be noted that although numerous putative sites were found to be occupied upon stimulation, many were clearly free of any protein-DNA interactions, indicating either their inability to interact with proteins in the in vivo context, or the absence of any mechanism to stimulate their respective binding factors.
Finally, an important finding was the absence of protein-DNA interactions in inactivated cells prior to the addition of LPS. This makes it unlikely that IRF-2 plays a role as a repressive regulator of iNOS gene expression, at least prior to initial gene activation. Nevertheless, the presence elsewhere in the gene of a silencer element which might repress iNOS transcription has been theorised previously (13) and cannot be ruled out.
In conclusion, in vivo footprinting analysis of the enhancer and promoter of the murine iNOS gene following an LPS stimulation, revealed the probable involvement of a variety of transcription factors, to a greater extent than had been previously realised. Despite the absence of a conserved enhancer element in the human iNOS 5′-UTR analysed up until now, this does not rule out its existence elsewhere in the gene. Moreover, the striking similarity between the human and mouse promoter regions adds further relevance to the work described here and makes the study of human iNOS transcriptional control using our approach a worthwhile proposition.
